Not checked for notices yet.
Ecteinascidin 743, a transcription-targeted chemotherapeutic that inhibits MDR1 activation
Shengkan Jin, Barbara Gorfajn, Glynn Faircloth and 1 more
Proceedings of the National Academy of Sciences of the United States of America · 2000
Cited by papers we hold 3
- Mechanisms of Resistance to Conventional Therapies for Osteosarcoma · 2021No notice
- Targeting Molecular Mechanisms Underlying Treatment Efficacy and Resistance in Osteosarcoma: A Review of Current and Future Strategies · 2020No notice
- Targeting Transcription Factors for Cancer Treatment · 2018No notice
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.